Background/Objectives: Dihydroquercetin (DHQ), also known as taxifolin, is a natural flavonoid which has anti-inflammatory and wound-healing biological effects. One of the main limitations for developing formulations with DHQ is its low solubility in water at room temperature. One of the high-potential co-formers for increasing its solubility is l-lysine, which has an aliphatic amino group in the side radical capable of entering into intermolecular interactions with the phenolic hydroxyl groups of DHQ. Methods: Several modifications were obtained using grinding, drying, and lyophilization methods. Subsequent evaluation was conducted using a combination of physicochemical and biological analytical methods. Results: Obtained modifications could be described as very easily soluble substances. The absence of the formation of new covalent bonds between the compounds during the formation of such systems was established. The glass transition effect was detected at 64 °C for the obtained films. It is important to note that as a result of studying the cytotoxic properties of the objects, a decrease in cytotoxicity was established during lyophilization of the mechanical mixture of the initial components. For these lyophilizates, the IC50 value was 0.025 mg/mL, 0.068 mg/mL, 0.145 mg/mL, and 0.288 mg/mL for the 3T3, HEK293, Caco-2, and HUVEC cell lines, respectively. Conclusions: Co-amorphous systems of DHQ and l-lysine in the form of films and lyophilizates were obtained and described. These objects may be interesting from the point of view of increasing the solubility of natural flavonoids, which solves one of the main problems in developing drugs based on them.
Co-Amorphous Systems Based on Dihydroquercetin and l-Lysine: Synthesis and Evaluation.
阅读:5
作者:Svotin Artem A, Korochkina Maria D, Khodyachikh Anastasia A, Kolesnikova Diana R, Taldaev Amir, Bocharov Eduard V, Dzuban Alexander V, Utenyshev Andrey N, Shilov Gennadii V, Zeng Youyan, Li Bo, Terekhov Roman P, Selivanova Irina A
| 期刊: | Pharmaceutics | 影响因子: | 5.500 |
| 时间: | 2025 | 起止号: | 2025 Nov 27; 17(12):1528 |
| doi: | 10.3390/pharmaceutics17121528 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
